Market Overview

BofA Upgrades Baxter International On 'Margin Story,' But Valuation Is Rich


In a report published Thursday, Bank of America Merrill Lynch analyst Bob Hopkins downgraded the rating on Baxter International Inc (NYSE: BAX) from Buy to Neutral, while lowering the price target from $78 to $40. Although the company is likely to be an interesting "margin story" following its recent spinoff, the stock valuation is rich at present.

Following the spin-off of Baxter's biopharmaceutical business into Baxalta Inc (NYSE: BXLT), the analyst believes that the former company is likely to see margin improvement in the medtech arena, with the potential for EPS growth of more than 20 percent in the near to intermediate term, as well as EPS growth in the double digits in the longer term.

However, even if Baxter manages to meaningfully exceed its own guidance, the stock appears fully valued already on almost all valuation metrics.

"Because BAX is under-earning today, we value BAX based on out-year earnings and cash flow. We do not add the value of BAX's stake in Baxalta to BAX's valuation because that equity stake in Baxalta will likely be gone within a year as it will be used to pay down debt and fund the pension," Hopkins said.

Baxter's stake in Baxalta is expected to drive the former company's out-year earnings. The analyst believes, therefore, that if one accounts for the Baxalta stake in Baxter's valuation, it would imply double counting.

"BAX looks less expensive on EV/EBITDA, but that metric does not capture the impact of BAX's high capex spending over the next few years. BAX will have $2-$3bln in balance sheet flexibility, which could be a source of potential upside, but we do not expect any moves near-term," the Bank of America report added.

The analyst expects Baxter's new dividend yield to be in the 1 percent range, based on the company's 35 percent payout target.

Latest Ratings for BAX

Sep 2020Argus ResearchDowngradesBuyHold
Jul 2020Raymond JamesMaintainsOutperform
Jul 2020Morgan StanleyMaintainsEqual-Weight

View More Analyst Ratings for BAX
View the Latest Analyst Ratings


Related Articles (BAX)

View Comments and Join the Discussion!

Posted-In: Bank of America Merrill Lynch Bob HopkinsAnalyst Color Downgrades Price Target Analyst Ratings

Latest Ratings

JBLRBC CapitalMaintains38.0
COSTRBC CapitalMaintains412.0
COSTMKM PartnersMaintains325.0
MTNTruist SecuritiesMaintains243.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at